关注公众号，点击公众号主页右上角" ··· "，设置星标 "⭐" ，关注 鑫椤锂电 资讯~ 本文来源：储能前沿 3月16日， 蓝晓科技公 告称，公司与HANACOLLA S.A.签订的《3000吨电池级碳酸锂提锂装置销售合 同》因项目整体规划发生变化，经双方协商一致同意终止。 鑫椤报告预售： 2025-2029年全球锂电池应用市场运行趋势及竞争策略研究报告 根据此前公告，蓝晓科技拟向HANACOLLA销售盐湖提锂系统装置，合同金额2500万美元（约合人民币 1.72亿元）。 公告中提到，上述合同部分已履行。双方将放弃原合同及本协议项下对对方提出任何权益主张的权利； 同时，终止协议签署之日3个工作日内，HANACOLLA向蓝晓科技支付150万美元；HANACOLLA放弃要 求蓝晓科技退还已支付的250万美元预付款。 蓝晓科技表示，此次终止协议的签订，不会对公司当期经营业绩及财务状况产生重大影响，也不存在损害 公司及全体股东利益的情形。协议执行中，双方始终基于项目高质量运行保持良好协作和良好伙伴关系。 该协议签订后，公司将继续与HANACOLLA保持良好沟通，跟进项目最新进展，寻找潜在合作机会。 预订电话：189 ...

| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2026-016 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | | 西安蓝晓科技新材料股份有限公司 1.双方同意自《终止协议》签订之日起，《销售合同》终止； 2.《终止协议》签署之日 3 个工作日内，HANACOLLA 向公司支付 150 万 美元；HANACOLLA 放弃要求公司退还已支付的 250 万美元预付款； 3.双方放弃原合同及本协议项下对对方提出任何权益主张的权利。 关于盐湖提锂日常经营合同的终止公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、合同基本情况 西安蓝晓科技新材料股份有限公司（以下简称"公司"）与 HANACOLLA S.A. （以下简称"HANACOLLA"）签订《3000 吨电池级碳酸锂提锂装置销售合同》 （以下简称"《销售合同》"），公司拟向 HANACOLLA 销售盐湖提锂系统装置， 合同金额 2500 万美元。具体内容详见公司于 2023 年 6 月 15 日在中国证监会指 定的创业板信息披露网站 ...

Investment Rating - The report maintains a "Recommended" rating for the pharmaceutical industry as of March 16, 2026 [1] Core Insights - The report emphasizes the importance of products with price leadership amid rising costs in the supply chain due to geopolitical tensions and policy changes affecting raw material prices [2] - The report highlights the significant price increases in pharmaceutical raw materials, particularly vitamins and amino acids, which have seen price increases of 40.54% and 84.66% respectively since the beginning of the year [2] - The report notes the approval of China's first invasive brain-machine interface, marking a significant milestone in the medical device sector [5] - The report indicates a strong trend in China's innovative pharmaceuticals going global, with a notable increase in licensing-out transactions [6] Summary by Sections 1. Supply Chain Dynamics - The report discusses the impact of rising prices in upstream chemical products on pharmaceutical raw materials, stressing that the ability to pass on these costs is crucial for maintaining profitability [2] - It mentions that 90% of monitored products have seen price increases, with the chemical product price index rising by 28.52% since the beginning of the year [2] 2. Market Trends in Disposable Gloves - The report details the price increases in disposable nitrile gloves and PVC gloves due to rising costs of raw materials like butadiene and acrylonitrile, which have increased by 84.43% and 47.30% respectively [3] - It notes that the domestic utilization rate for nitrile gloves has improved, and export prices have been rising since late 2025 [3] 3. Regulatory Environment - The report highlights the impact of dual-use item management on the pricing of key materials, creating significant price disparities between domestic and international markets [4] - It suggests that stricter controls on resources like rare earths could enhance the competitive advantage of domestic medical products [4] 4. Innovations in Medical Devices - The report discusses the approval of the brain-machine interface by the National Medical Products Administration, which is expected to open new market opportunities [5] - It outlines the potential for significant market growth in this area, given the high number of spinal cord injury patients in China [5] 5. International Expansion of Chinese Pharmaceuticals - The report notes that there have been 39 licensing-out transactions in the innovative drug sector, with upfront payments totaling approximately $2.953 billion [6] - It emphasizes that the trend of Chinese pharmaceuticals going global continues to strengthen, with a focus on small nucleic acid drugs and dual antibodies [7] 6. Stock Recommendations - The report recommends focusing on raw material suppliers with price leadership, such as Zhejiang Medicine and Chuan Ning Biological, and highlights companies like Inco Medical and Blue Sail Medical in the disposable glove sector [8] - It also suggests monitoring companies involved in the invasive brain-machine interface and small nucleic acid drugs, indicating potential for growth in these areas [8]

Core Viewpoint - The article emphasizes the importance of maintaining laboratory instruments in optimal condition to meet the demands of high-intensity testing tasks in the new year, highlighting the services provided during the sixth Customer Care Season by the Instrument Information Network [1]. Group 1: Event Overview - The theme for this year's event is "'Together in Instruments," featuring hundreds of engineers and a week-long online after-sales live broadcast to support researchers in their scientific endeavors [2]. - The event includes free on-site inspections valued at over 10,000 yuan, with original factory experts addressing potential issues directly [2]. Group 2: Participating Brands - The event features participation from various brands including Thermo Fisher, Agilent, Hitachi, Shimadzu, and others, providing specialized support for different types of analytical instruments [2]. Group 3: Event Schedule - The schedule includes specific sessions for different brands, such as: - March 10: Thermo Fisher after-sales live broadcast focusing on maintenance tips for mass spectrometry and gas chromatography [4]. - March 11: Shimadzu's session on atomic absorption maintenance and gas chromatography performance [5]. - March 12: Hitachi's session on electron microscope maintenance and amino acid analyzer guidelines [5]. Group 4: Expert Contributions - Various experts from participating companies will lead the sessions, sharing their knowledge on maintenance and troubleshooting for specific instruments, enhancing the overall service quality [7][8].

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1][28]. Core Insights - The global chemical industry is entering a significant upward cycle driven by anti-involution and AI demand, with China's leading companies benefiting from solid cost and efficiency advantages. The industry is expected to see a substantial increase in free cash flow as capacity expansion slows, transforming companies from cash-consuming entities to cash-generating ones. The upcoming peak season for chemicals is anticipated to enhance profitability, making it crucial to focus on demand, value, and supply dynamics for investment opportunities [3][28]. Summary by Sections Recent Trends - As of March 5, 2026, the Guohai Chemical Prosperity Index stands at 99.35, reflecting a 5.16 increase from February 26, 2026 [1]. Performance Metrics - The basic chemical sector has shown a performance increase of 7.4% over the past month, 23.6% over the past three months, and 50.8% over the past year [4]. Investment Opportunities 1. **Value-Driven Opportunities**: Potential for increased dividend yields in sectors such as coal chemicals (e.g., Hualu Hengsheng, Luxi Chemical), oil refining (e.g., Hengli Petrochemical, Sinopec), pesticides (e.g., Yangnong Chemical), and potassium fertilizers (e.g., Salt Lake Industry) [3]. 2. **Supply-Driven Opportunities**: Focus on domestic anti-involution policies and European capacity exits, with key players including PTA/Polyester (e.g., Xinfengming, Tongkun), glyphosate and organosilicon (e.g., Xingfa Group), and industrial silicon (e.g., Hoshine Silicon) [6]. 3. **Demand-Driven Opportunities**: Highlighting sectors benefiting from large-scale opportunities, including gas turbines (e.g., Zhenhua Group), refrigerants (e.g., Juhua), and energy storage (e.g., Chuanheng) [6]. Key Companies and Earnings Forecasts - The report tracks several key companies with their respective earnings per share (EPS) forecasts for 2024 to 2026, indicating a positive outlook for many, including Dongfang Shenghong, Hubei Yihua, and Wanhua Chemical [29]. Market Observations - The report notes that geopolitical tensions, particularly in the Middle East, are likely to drive oil prices higher, benefiting companies like China National Petroleum and CNOOC, while also increasing costs for petrochemical products [9][13]. Price Trends - Recent price increases have been observed in various chemical products, including MDI and TDI, with significant upward movements in raw material costs due to geopolitical events [14][18]. Conclusion - The chemical industry is positioned for a favorable outlook, driven by structural changes in supply and demand dynamics, with a focus on companies that can leverage these trends for growth and profitability [28].

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [4][5]. Core Insights - The geopolitical conflict between the US and Iran is expected to drive up prices for methanol, ethylene glycol, and urea, with a comprehensive price increase anticipated for chemical products after the holiday [4]. - The report highlights the impact of differentiated electricity pricing in Shaanxi, which may accelerate the exit of outdated production capacities and improve industry dynamics [4]. - The overall capital expenditure in the chemical sector is at its peak, with low inventory levels in the supply chain, suggesting a favorable environment for price increases as downstream production resumes post-holiday [4]. Industry Dynamics - Current macroeconomic judgment indicates that oil prices are expected to remain in a relatively loose range, with Brent crude projected between $60 and $75 per barrel due to delayed OPEC+ production increases and stable demand recovery [5]. - Coal prices are expected to stabilize at a low level in the medium to long term, while natural gas costs may decrease as the US accelerates its export facility construction [5]. - The report notes that the January PPI for industrial products decreased by 1.4% year-on-year but increased by 0.4% month-on-month, indicating a slight recovery in the manufacturing sector [7]. Investment Analysis - The report suggests focusing on four main areas for investment: 1. Textile and apparel chain, benefiting from high demand growth and improved supply dynamics [4]. 2. Agricultural chemicals, with stable fertilizer demand and increasing transgenic penetration supporting long-term pesticide demand [4]. 3. Export-related chemical products, as overseas inventories are at historical lows and interest rates are expected to decline [4]. 4. "Anti-involution" policies leading to accelerated clearance of outdated capacities in various sectors [4]. Key Material Focus - The report emphasizes the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, as well as in lithium battery and fluorine materials [4].

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1] Core Insights - The report highlights the solid cost and efficiency advantages of leading Chinese chemical companies, which are entering a long-term upward performance phase. The recovery in demand is expected to sustain the improvement in the performance of supply-constrained sectors. The carbon emission control measures are likely to lead to a re-evaluation of the Chinese chemical industry, with capacity expansion slowing down significantly. This is expected to enhance free cash flow and potential dividend yields for companies, transforming them from cash-consuming entities to cash-generating ones. The report emphasizes the importance of demand, value, and supply in identifying investment opportunities [2][29] Summary by Sections Recent Trends - As of February 26, 2026, the Guohai Chemical Prosperity Index stands at 94.19, reflecting a slight increase of 0.22 from February 19, 2026 [1] Performance Analysis - The basic chemical sector has shown a performance increase of 6.0% over the past month, 26.1% over the past three months, and 52.2% over the past year, significantly outperforming the CSI 300 index [4] Investment Opportunities - **Value-Driven Opportunities**: Companies such as Hualu Hengsheng, Luxi Chemical, and Baofeng Energy are highlighted for their potential dividend rate increases [2] - **Supply-Driven Opportunities**: Companies like Xin Fengming and Tongkun Co. are noted for benefiting from domestic supply constraints and European capacity exits [6] - **Demand-Driven Opportunities**: The report identifies companies in sectors such as gas turbines, refrigerants, and energy storage as key beneficiaries of growing demand [6][7] Key Companies and Earnings Forecast - The report provides a detailed earnings forecast for various companies, indicating a positive outlook for firms like Dongfang Shenghong, Hubei Yihua, and Baofeng Energy, with expected earnings per share (EPS) growth in the coming years [30] Market Dynamics - The report discusses the impact of geopolitical tensions on oil prices, which are expected to rise, benefiting companies like China Petroleum and China National Offshore Oil Corporation. It also notes potential supply shortages in methanol and urea due to disruptions in Iranian production [10][11] Price Trends - Recent price movements include a significant increase in battery-grade lithium carbonate prices, which rose by 19.18% week-on-week, driven by supply constraints and demand recovery [14] Conclusion - The report concludes that the chemical industry is entering a favorable cycle, driven by supply-side constraints and increasing demand, making it an attractive investment area [29]

| 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2026-015 | | --- | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | | 西安蓝晓科技新材料股份有限公司 关于控股股东股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存在虚 假记载、误导性陈述或重大遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）接到公司控股股东高 月静女士的通知，获悉高月静女士于近日将其质押的公司股份全部办理了解除质 押手续，现将有关情况公告如下： 中国证券登记结算有限责任公司出具的《解除证券质押登记通知》。 特此公告。 西安蓝晓科技新材料股份有限公司董事会 截至本公告披露日，上述股东及其一致行动人所持质押股份已全部解除质押， 具体情况如下： | 股东 | 持股 | | 本次解除质 | 本次解除质 | 占其所 | | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 数量 | 持股 比例 | ...

Core Viewpoint - The increasing trend of funds focusing on inquiry transfer projects, which offer shorter cycles and greater discounts, is aimed at enhancing capital utilization efficiency [1]. Group 1: Market Trends - Since 2026, 12 listed companies have conducted inquiry transfers, with notable participation from well-known public and private fund institutions such as E Fund, Huaxia Fund, and Nord Fund [1][2]. - The inquiry transfer of Guangdong Wannianqing Pharmaceutical Co., Ltd. involved a maximum transfer of 8 million shares at a price of 18.80 CNY per share, reflecting a discount rate of 91.66% compared to the closing price on the pricing benchmark date [2][3]. Group 2: Participant Analysis - Private and public funds are the main participants in inquiry transfers, with private funds having the highest subscription frequency from 2020 to 2025, totaling 577 times [3]. - Public funds led with 82 subscriptions among licensed financial institutions, followed by QFII and securities companies with 43 and 60 subscriptions, respectively [3]. Group 3: Performance Metrics - As of February 11, 2026, 11 out of 12 companies that conducted inquiry transfers had stock prices above the initial transfer price, with some institutions achieving floating profits exceeding 30% [4]. - For example, Jiangbolong's inquiry transfer price was 212.09 CNY per share, while its stock price reached 284.14 CNY, resulting in a floating profit rate of approximately 34% [4]. Group 4: Comparative Analysis with Private Placements - Inquiry transfers have shown superior returns and discount performance compared to private placements, with an average return of 49.52% for inquiry transfers in 2025, surpassing the 38.61% return from competitive private placements [4][5]. - The number of companies conducting inquiry transfers increased from 12 in 2021 to 180 in 2025, indicating a growing acceptance of this method [5]. Group 5: Strategic Insights - Inquiry transfers and private placements complement each other by offering different risk-return profiles, attracting various investment strategies [5]. - The focus on sectors such as semiconductors, AI hardware, and domestic software is expected to enhance the visibility and growth certainty of leading companies, making their equity attractive assets [5].

Group 1 - The chemical sector is experiencing a rebound, with the chemical ETF (516020) showing a significant increase of 1.77% as of the report, peaking at a 1.98% rise during the trading session [1][2] - Key stocks in the sector include New Chemical Materials, which surged over 8%, and other notable gainers such as New Fengming, Rongsheng Petrochemical, and Tongkun Co., all showing increases of over 4% [1][2] - Recent reports from major foreign investment firms, including UBS and Morgan Stanley, have upgraded their outlook on the Chinese chemical industry, predicting a new upward cycle from 2026 to 2028 due to multiple positive factors [1][3] Group 2 - Guohai Securities suggests that the re-evaluation of the Chinese chemical industry could lead to a significant slowdown in global capacity expansion, potentially transforming the industry from a cash-consuming entity to a cash-generating one [3] - The chemical ETF (516020) tracks the CSI sub-sector chemical industry index, covering popular themes such as AI computing power, de-involution, robotics, and new energy [3]